Regeneron Pharmaceuticals, Inc.

Filings by Regeneron Pharmaceuticals, Inc. span 2 companies, the busiest being Adverum Biotechnologies, Inc. and Decibel Therapeutics, Inc. We count 4 filings; the first trade dates from 5 August 2014 and the latest from 17 February 2021.

On the market, this insider has only ever bought: 1 purchase, €7.5M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The latest filing, published on 18 February 2021, reports a transaction in Decibel Therapeutics, Inc. The clock since the last published purchase (5 August 2014) now reads 4,479 days. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.